Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
GlioPharma ApS
APS
Dissolved
Reklamebeskyttelse
CVR 37256641
Birkemose Allé 27, 6000
Kolding
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
·
NACE 721900
Est. 2015 · 10 years old
— employees
Overvåg
Share
Denmark
/
Companies
/
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
/
GlioPharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2017
0M
0%
2018
Income statement
DKK thousands
Item
2017
2018
Gross profit
12
-15
Staff expenses
-0
-0
EBITDA
12
-15
Depreciation & amort.
-0
-0
EBIT
12
-15
Net financials
-5
-7
Profit before tax
7
-22
Tax
3
-0
Net profit
4
-22
Balance sheet
DKK thousands
Item
2017
2018
Total assets
184
169
Equity
54
33
Long-term debt
104
0
Short-term debt
26
136
Total debt
130
136
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-1450500.0%
This company
2017
2018
Soliditetsgrad
19.5%
This company
38.2%
Market median
-49% vs market
2017
2018
Egenkapitalforrentning
-65.8%
This company
18.4%
Market median
-458% vs market
2017
2018
Nettoresultatgrad (af bruttofortjeneste)
-2160000.0%
This company
2017
2018
Aktivomsætning (af bruttofortjeneste)
-0.09×
This company
2017
2018
Gæld/egenkapital
4.14×
This company
0.62×
Market median
-568% vs market
2017
2018
Annual reports & filings
Annual report 2018
Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2015-11-25 – 2017-04-30
View
PDF
More on GlioPharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
